To evaluate the transferability of deep learning (DL) models for the early detection of adverse events to previously unseen hospitals.
No takes yet. Share an insight, caveat, or question.
Rockenschaub et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: